Literature DB >> 10364701

Cerebral salt-wasting syndrome. We need better proof of its existence.

M S Oh1, H J Carroll.   

Abstract

It is widely believed that the cerebral salt-wasting syndrome (CSWS) exists as an entity distinct from the syndrome of inappropriate ADH secretion, and that it is characterized by evidence of severe renal salt wasting that results in volume depletion and hyponatremia. Proof of the existence of CSWS as an entity requires documentation of renal salt wasting and volume depletion. The present review has been undertaken to examine the evidence that the CSWS is a separate entity. In this effort, we have discussed various methods of documentation of volume depletion, and then reviewed reported cases of CSWS to determine whether volume depletion and renal salt wasting have been clearly demonstrated. Our review has led us to conclude that not one case of purported CSWS has demonstrated clear evidence of volume depletion and renal salt wasting. If renal salt wasting had been proven in these cases, we would conclude that the likely site of renal salt transport was the proximal tubule. The proximal site of salt transport defect has been suggested by the absence of hyperreninemia and hypokalemia, which would be a distinguishing feature of Bartter's syndrome and Gitelman's syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364701     DOI: 10.1159/000045385

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  14 in total

1.  Clinical evaluation of hyponatremia and hypovolemia in critically ill adult neurologic patients: contribution of the use of cumulative balance of sodium.

Authors:  Paolo Gritti; Luigi Andrea Lanterna; Lidia Rotasperti; Matteo Filippini; Simone Cazzaniga; Carlo Brembilla; Tatyana Sarnecki; Ferdinando Luca Lorini
Journal:  J Anesth       Date:  2014-03-21       Impact factor: 2.078

2.  Diagnosis and management of cerebral salt wasting (CSW) in children: the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP).

Authors:  Philipp von Bismarck; Tobias Ankermann; Paul Eggert; Alexander Claviez; Michael J Fritsch; Martin F Krause
Journal:  Childs Nerv Syst       Date:  2006-04-11       Impact factor: 1.475

3.  Cerebral salt wasting syndrome in a patient affected of spontaneous frontoparietal subdural haematoma.

Authors:  Mariaina Cerdá-Esteve; Mariona Badia; Javier Trujillano; Cecília Vilanova; Javier Maravall; Dídac Mauricio
Journal:  BMJ Case Rep       Date:  2009-10-13

4.  Hyponatremia in neurological patients: cerebral salt wasting versus inappropriate antidiuretic hormone secretion.

Authors:  Serge Brimioulle; Carlos Orellana-Jimenez; Adel Aminian; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2007-10-19       Impact factor: 17.440

Review 5.  Hyponatremia and brain injury: historical and contemporary perspectives.

Authors:  Matthew A Kirkman; Angelique F Albert; Ahmed Ibrahim; Doris Doberenz
Journal:  Neurocrit Care       Date:  2013-06       Impact factor: 3.210

6.  More on renal salt wasting without cerebral disease: response to saline infusion.

Authors:  Solomon Bitew; Louis Imbriano; Nobuyuki Miyawaki; Steven Fishbane; John K Maesaka
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

Review 7.  Tumor-related hyponatremia.

Authors:  Adedayo A Onitilo; Ebenezer Kio; Suhail A R Doi
Journal:  Clin Med Res       Date:  2007-12-17

8.  Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: a single-center experience.

Authors:  Charalampos Pierrakos; Fabio Silvio Taccone; Guy Decaux; Jean-Louis Vincent; Serge Brimioulle
Journal:  Ann Intensive Care       Date:  2012-05-30       Impact factor: 6.925

9.  Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases.

Authors:  Maurice Laville; Volker Burst; Alessandro Peri; Joseph G Verbalis
Journal:  Clin Kidney J       Date:  2013-11

10.  Neurosurgical Hyponatremia.

Authors:  Mark J Hannon; Christopher J Thompson
Journal:  J Clin Med       Date:  2014-10-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.